Starling Oncology (STLNW) Cash from Operations Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 51.15% |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | -21.81% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 14.00% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 52.99% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | -86.20% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.75 Bn | - | -10.15% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | -9.16% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | -27.06% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | -1.41% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 217.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217.04% |
| Mar 31, 2026 | 55.59% |
| Dec 31, 2025 | -19.17% |
| Sep 30, 2025 | -1,642.12% |
| Jun 30, 2025 | 34.85% |
| Mar 31, 2025 | 68.60% |
| Dec 31, 2024 | 202.75% |
| Sep 30, 2024 | 109.86% |
| Jun 30, 2024 | -80.83% |
| Mar 31, 2024 | -2.79% |
| Dec 31, 2023 | 72.19% |
| Sep 30, 2023 | 59.26% |
| Jun 30, 2023 | 16.56% |
| Mar 31, 2023 | 9.00% |
| Dec 31, 2022 | 40.02% |
| Sep 30, 2022 | -661.44% |
| Jun 30, 2022 | -45.57% |
| Mar 31, 2022 | -3,759.70% |
| Dec 31, 2021 | -2,412.82% |
| Sep 30, 2021 | -3,759.17% |